Abstract
The Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee guidelines for the use of growth hormone were first published in 1983, near the end of the era of human pituitary-derived growth hormone (GH), and again in 1995, a decade after the introduction of recombinant human (rh)GH. 1. Guidelines for the use of growth hormone in children with short stature. A report by the Drug and Therapeutics Commitee of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr. 1995; 6: 857-867 Google Scholar The Lawson Wilkins Pediatric Endocrine Society also endorsed an international consensus document led by the Growth Hormone Research Society published in 2000. 2. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab. 2000; 85: 3990-3993 Crossref PubMed Scopus (855) Google Scholar This report serves to update those guidelines with an emphasis on new recommendations. The recommendations included here are limited primarily to the use of GH in infants, children and adolescents.
Submitted Version (
Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
